trending Market Intelligence /marketintelligence/en/news-insights/trending/YNhOyn8Oj5jKBW_wYWHJMw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Tandem Diabetes stockholders approve reverse stock split

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Tandem Diabetes stockholders approve reverse stock split

Tandem Diabetes Care, Inc. stockholders approved the implementation of a 1-for-10 reverse stock split of the company's issued and outstanding common stock.

Following the stock split, Tandem's issued and outstanding common stock will be about 5.5 million shares. The company's authorized common shares will remain at 100 million shares.

Tandem's common stock will trade on the Nasdaq Global Market on a split-adjusted basis beginning Oct. 10.

American Stock Transfer & Trust Co. LLC is acting as the exchange agent for the reverse stock split.